The Leading Metastasis and Angiogenesis Models

Customized service for all your in vivo cancer drug screening, discovery, evaluation and development needs.

Develop New Effective Drugs for Metastasis and Angiogenesis

MetaMouse®/AngioMouse®/OncoBrite®/GeneBrite®

Green/Red fluorescent protein (GFP, RFP) tumor expression for quantitative functional imaging.
 In vivo drug discovery and evaluation for tumor growth, metastasis, angiogenesis.
 Whole-body functional imaging of drug efficacy on tumor growth, metastasis, angiogenesis, gene expression.
 Real-time in vivo visualization of tumor growth, metastasis, angiogenesis, gene expression.
More than 60 GFP/RFP-expressing tumor models available for MetaMouse®/AngioMouse®.
 Orthotopic metastatic MetaMouse®/AngioMouse®  models.
 All types of agents can be evaluated: small molecules, proteins, genes.
 In vivo high-throughput drug screening and evaluation.
 Customized contract research for all types of drug discovery and evaluation. 

 

Olympus-AntiCancer, Inc. Technology Partnership 

Olympus OV100 Whole Mouse Imaging System: 

TO VIEW WHOLE METAMOUSE POWER POINT PRESENTATION CLICK HERE:  

Comparison of GFP and Luciferase Imaging* 

Method Minimum cells imageable in vitro Minimum cells imageable in vivo Need for substrate? Need for anesthesia? Method of visualization Multicolor imaging
GFP 1 1 No No Direct Imaging Yes
Luciferase 300 3000 Yes Yes Photon counting (pseudo-color) No

* THE LANCET Oncology 3, p546-556, 2002 [PDF] 

NEW! METAMOUSE®/ANGIOMOUSE®  WHOLE-BODY IMAGING WITH GFP/RFP!

Green/Red Fluorescent Protein to visualize, image and quantify drug efficacy on tumor growth, metastasis, angiogenesis and gene expression in real time. 

Whole-body imaging of liver metastases in MetaMouse®/OncoBrite® Skeletal metastases in MetaMouse®/OncoBrite® Whole-body imaging of tumor angiogenesis in AngioMouse® Whole-body imaging of single glioma cells in the brain in MetaMouse®/OncoBrite® Whole-body dual color imaging of GFP and RFP mammary tumors in MetaMouse®/OncoBrite® Whole-body imaging of gene expression in the liver in GeneBrite® model

WHOLE-BODY REAL TIME IMAGING OF METASTATIC GROWTH AND DRUG RESPONSE

DRUG RESPONSE ON HUMAN METASTATIC TUMORS GROWING ORTHOTOPICALLY IN MICE

Control

Drug Treated

Days

0 2 4 6 8

Recent MetaMouse®/Oncobrite®/AngioMouse®/GeneBrite® references:

 Metamouse® US Patents: 5,491,284; 5,569,812; European Patent 0437488; Japanese Patent 2,664,261. GFP US Patents: 6,232,523; 6,251,384; 6,235,967; 6,235.968; 6,649,159; 6,759,038; 6,905,831; Australian 749,338.

Novel drugs and indications discovered with MetaMouse® and MetaMouse® GFP/RFP models

Organ-specific models-MetaMouse®

GFP models-OncoBrite®

Angiogenesis models-AngioMouse®

Bone metastases

Cover Stories

Molecular Imaging of Chemotherapy

MetaMouse® references

 

7917 Ostrow St., San Diego, CA 92111 Tel: 858-654-2555 Fax: 858-268-4175 

http://www.anticancer.com/ 

E-Mail:  all@anticancer.com